|
Transitioning From Discovery to Lead Optimization: Peptide Synthesis Applications in Modern Peptide Drug Development, Upcoming Webinar Hosted by Xtalks
Friday, July 19, 2024
In this free webinar, learn about optimizing the structure-activity relationship (SAR) process in peptide drug development, including designing a robust synthesis, analyzing information from various disciplines in the SAR design for ensured success and the importance of chemical flexibility in the design and thorough investigation of SAR. The featured speaker will also highlight how crucial peptide design is to the drug discovery and development process.
TORONTO, July 11, 2024 /PRNewswire-PRWeb/ -- Discover an informative webinar providing insights into the pivotal role of peptide synthesis in modern drug development.
They will also share insights into how to optimize an initial peptide of interest into a quality lead molecule using practical examples to illustrate how peptide synthesis design and application can affect the drug development process.Peptides have become crucial in the quest for developing the most potent drug. Powerful display technology, combinatorial synthesis or in-silico design often build the foundation to fuel a target-based development project rapidly and efficiently with promising hits.
However, transforming a naïve peptide hit into a quality drug molecule involves many facets of drug discovery and can cause significant bottlenecks during the development cycle. Aside from the apparent collaborative nature required of the various disciplines involved, the creative and flexible nature of the structure-activity relationship (SAR)-driven molecular structure optimization, including sequence optimization, modifications and conjugations, is a critical component that can make or break a program.
In this webinar, the attendees will learn about designing robust syntheses to enhance the SAR process, including which interdisciplinary information is crucial for a successful SAR design. The speaker will also focus on the importance of chemical flexibility, which permits creative design and thorough investigation in SAR studies. They will also share insights into how to optimize an initial peptide of interest into a quality lead molecule using practical examples to illustrate how peptide synthesis design and application can affect the drug development process.
Register for this webinar to gain practical insights and examples on optimizing peptide synthesis and application to navigate bottlenecks and enhance the drug development cycle.
Join William C Blackwell III, Director of Chemistry, Aktis Oncology, RTP, NC, for the live webinar on Tuesday, July 30, 2024, at 10am EDT (3pm BST/UK)
For more information, or to register for this event, visit Transitioning From Discovery to Lead Optimization: Peptide Synthesis Applications in Modern Peptide Drug Development.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit https://xtalks.com/why-host-a-webinar/
Media Contact
Soumya Shashikumar, Xtalks, +1 (416) 977-6555 x371, skumar@xtalks.com, https://xtalks.com
View original content to download multimedia:https://www.prweb.com/releases/transitioning-from-discovery-to-lead-optimization-peptide-synthesis-applications-in-modern-peptide-drug-development-upcoming-webinar-hosted-by-xtalks-302194178.html
SOURCE Xtalks
|
|
|
|
|
|
 |
VIAVI Highlights Test Solutions for AI Infrastructure Development, Manufacturing and Deployment at OFC 2025 | Mar 28, 2025
|
|
Orium Launches Composable Accelerator for Shopify | Mar 28, 2025
|
|
Oracle Helps Customers Boost Employee Engagement with Strategic Communications and Internal Events | Mar 28, 2025
|
|
ThreatQuotient positioned as a Leader in the SPARK Matrix(TM): Digital Threat Intelligence Management, 2025 by QKS Group | Mar 28, 2025
|
|
Madame Rachida Dati, French Minister of Culture, has granted official recognition to thierry Ehrmann's Abode of Chaos as a 'total work of art', the global headquarters of Artprice by Artmarket. | Mar 28, 2025
|
|
Datacenter Dynamics Makes History with LoneStar - Becoming the World's First Magazine to Reach the Moon | Mar 28, 2025
|
|
Oracle Named a Leader in Configure, Price, Quote by Independent Research Firm | Mar 28, 2025
|
|
Nosto reports 323% growth of Personalized Search after 2024 Gartner MQ inclusion | Mar 28, 2025
|
|
Wealthbox Expands to Canada with In-Country Data Hosting | Mar 28, 2025
|
|
Western Union forms strategic partnership with HCLTech to transition to an AI led platform operating model | Mar 28, 2025
|
|
|
|
